Vivos Therapeutics, Inc.
VVOS
$4.20
-$0.40-8.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.23% | -10.30% | 281.01% | 538.77% | 75.11% |
| Total Receivables | 313.42% | 36.76% | 112.87% | 99.12% | 20.80% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 25.45% | 15.16% | 27.11% | -17.56% | -48.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.29% | -0.11% | 203.66% | 272.75% | 46.99% |
|
|
|||||
| Total Current Assets | -14.29% | -0.11% | 203.66% | 272.75% | 46.99% |
| Net Property, Plant & Equipment | 87.06% | -8.09% | -6.75% | -6.38% | -6.96% |
| Long-term Investments | 197.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 197.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 463.29% | -12.25% | -11.90% | -11.55% | -11.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.61% | -30.19% | -29.64% | -10.10% | -10.39% |
| Total Assets | 64.33% | -4.42% | 42.44% | 48.75% | 15.22% |
|
|
|||||
| Total Accounts Payable | -13.07% | -51.74% | -48.81% | -29.65% | 53.06% |
| Total Accrued Expenses | 5.35% | -27.66% | -4.28% | 6.87% | 12.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 78.93% | -3.31% | 0.63% | 5.43% | 8.28% |
| Total Finance Division Other Current Liabilities | -23.18% | -52.56% | -49.96% | -53.58% | -58.76% |
| Total Other Current Liabilities | -23.18% | -52.56% | -49.96% | -53.58% | -58.76% |
| Total Current Liabilities | -3.27% | -41.75% | -31.71% | -28.48% | -21.29% |
|
|
|||||
| Total Current Liabilities | -3.27% | -41.75% | -31.71% | -28.48% | -21.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 130.86% | -33.38% | -31.95% | -29.56% | -27.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 174.11% | -29.15% | -12.72% | -4.25% | 9.24% |
| Total Liabilities | 125.91% | -38.74% | -28.97% | -25.21% | -18.45% |
|
|
|||||
| Common Stock & APIC | 11.95% | 15.46% | 19.99% | 22.72% | 18.34% |
| Retained Earnings | -14.50% | -11.61% | -11.97% | -14.15% | -13.89% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -27.79% | 657.22% | 1,835.28% | 16,563.04% | 201.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.79% | 657.22% | 1,835.28% | 16,563.04% | 201.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.79% | 657.22% | 1,835.28% | 16,563.04% | 201.38% |
|
|
|||||